On ECHEMI
Home > Drugs > Cervical cancer
Cervical cancer
Cervical cancer is the only gynecological malignancy with a clear etiology, and is associated with persistent infection with high-risk human papillomavirus. HPV is a double-stranded DNA virus that mainly infects the epithelium of the skin and mucous membranes, causing different lesions. Other high-risk factors include: 1. Sexual behavior: starting sexual life too early, multiple sexual partners; 2. Menstrual and childbirth factors: poor menstrual hygiene, prolonged menstruation, early childbearing, multiple births, etc.; 3. Smoking; 4. Long-term use of oral contraceptives, etc. The earliest symptoms are mainly vaginal bleeding and vaginal discharge. It is the third most common malignant tumor among women worldwide, second only to breast cancer and colorectal cancer.
  • Site of disease:

    Uterus
  • Infectious :

    Not contagious
  • Frequent population:

    Women aged 40 to 60, in the sexually active period...
  • Related symptoms:

    Purulent and bloody leucorrhea weight loss nipple-like hyperplasia changes continuous vaginal bleeding vaginal metastasis
  • Concurrent disease:

Related Drugs
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Bei Jing Scrianen Pharmaceutical Co., Ltd.

Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Zhejiang Hisun Pharmaceutical Co., Ltd.

Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Huzhou Zhanwang Pharmaceutical Co., Ltd.

Methotrexate tablets
Indication: 1. All types of acute leukemia, especially acute lymphocytic leukemia, malignant lymphoma, non-Hodgkin's lymphoma, mycosis fungoides, and multiple myelopathy; 2. Head and neck cancer, lung cancer, various soft tissue sarcomas, and psoriasis; 3. Breast cancer, ovarian cancer, cervical cancer, malignant hydatidiform mole, choriocarcinoma, and testicular cancer.
Manufacturer:

Hunan Zhengqing Pharmaceutical Co., Ltd.

Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:

Shandong Ruiying Pioneer Pharmaceutical Co., Ltd.

Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Manufacturer:

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Ifosfamide
Indication: 1. This product has a wide anti-tumor spectrum and is mainly suitable for soft tissue tumors, testicular tumors, malignant lymphomas, lung cancer, breast cancer, ovarian cancer, cervical cancer and childhood tumors; 2. Used for anti-tumor: leukemia, spermatogonial testicular cancer, lung cancer, non-Hodgkin's lymphoma, cervical cancer, ovarian cancer and recurrent and refractory solid tumors.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.